Acquisition strengthens IDEXX’s connected diagnostic and software ecosystem with AI-native workflow capabilities that enhance efficiency, clinical decision-making, and diagnostic utilization. Read full article
CoreMap, Inc., a medical technology company developing advanced tools to improve the treatment of atrial fibrillation (“AF”), announced the closing of its $37 million Series
DataFeedWatch and Revmatics combine product feed distribution with Lumara™ AI to improve scalable shopping performance and reduce waste. Read full article
Sumitomo Rubber Industries, Ltd. has signed an acquisition agreement on August 27 with Viaduct, Inc. a U.S-based AI solutions startup, for a total of USD
Streaming Giants Are Reinventing Television Advertising Through Interactive Shopping and Free Content Read full article
The intelligent robotics landscape is undergoing a fundamental shift in how value is created and captured. While AI-native startups and tech giants bring software expertise,
Many industries are searching for the “new normal,” even five years after the global pandemic rocked their foundations. Read full article
Bentley Systems, Incorporated (Nasdaq: BSY), an Exton, PA-based infrastructure engineering software company, announced the acquisition of Blyncsy, a Salt Lake City, Utah-based provider of artificial
Getting the best outcome requires great preparation, great story-telling and having an experienced senior advisor that you fully trust has your best interests in mind
A startling trend has begun to emerge in technology M&A: boutique firms are on the rise. Read full article
Securities are offered through Finalis Securities LLC Member FINRA / SIPC. Ignatious is not a registered broker-dealer, and Finalis Securities LLC and Ignatious are separate, unaffiliated entities. Finalis Securities LLC, Office of Supervisory Jurisdiction is located at 450 Lexington Ave, New York, NY 10017, 800-962-0418.
Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck | Finalis Form Customer Relationship Summary (“Form CRS”)
ignatious.com (the “Ignatious Website”) is a website operated by Ignatious. This website is for informational purposes only, is not an offer, solicitation, recommendation, or commitment for any transaction or to buy or sell any security or other financial product, and is not intended as investment advice or as a confirmation of any transaction. Products and services on this website may not be available for residents of certain jurisdictions. Please consult with a Finalis Securities’ registered representative regarding the product or service in question for further information. Investments involve risk and are not guaranteed to appreciate. Any market price, indicative value, estimate, view, opinion, data, or other information herein is not warranted as to completeness or accuracy, is subject to change without notice, and Ignatious along with Finalis Securities LLC accepts no liability for its use or to update it or keep it current.
Investing in private placements involves a high degree of risk. These investments may be illiquid, speculative, and subject to substantial restrictions on transferability. Investors may lose all or part of their investment and should only invest capital they can afford to lose. Prospective investors should conduct their own due diligence and consult with their legal, tax, and financial advisors prior to making any investment decision. For your reference, Finalis’ Form CRS describes the services that we provide, how we are compensated, and other important information about Finalis Securities LLC.